ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - BIT:1LLY - US5324571083 - Common Stock
709.1 EUR
+12.2 (+1.75%)
1LLY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. While 1LLY has a great profitability rating, there are some minor concerns on its financial health. 1LLY is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year 1LLY was profitable.
1LLY had a positive operating cash flow in the past year.
Each year in the past 5 years 1LLY has been profitable.
1LLY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1LLY has a Return On Assets of 13.67%. This is amongst the best in the industry. 1LLY outperforms 87.04% of its industry peers.
1LLY's Return On Equity of 75.52% is amongst the best of the industry. 1LLY outperforms 96.30% of its industry peers.
1LLY has a better Return On Invested Capital (29.63%) than 94.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1LLY is significantly above the industry average of 14.71%.
The 3 year average ROIC (21.71%) for 1LLY is below the current ROIC(29.63%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROIC | 29.63% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
1LLY's Profit Margin of 25.91% is amongst the best of the industry. 1LLY outperforms 92.59% of its industry peers.
1LLY's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 42.13%, 1LLY belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
1LLY's Operating Margin has improved in the last couple of years.
1LLY has a Gross Margin of 82.64%. This is amongst the best in the industry. 1LLY outperforms 85.19% of its industry peers.
In the last couple of years the Gross Margin of 1LLY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1LLY is creating value.
Compared to 1 year ago, 1LLY has about the same amount of shares outstanding.
The number of shares outstanding for 1LLY has been reduced compared to 5 years ago.
Compared to 1 year ago, 1LLY has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 7.31 indicates that 1LLY is not in any danger for bankruptcy at the moment.
1LLY has a Altman-Z score of 7.31. This is amongst the best in the industry. 1LLY outperforms 94.44% of its industry peers.
A Debt/Equity ratio of 1.87 is on the high side and indicates that 1LLY has dependencies on debt financing.
1LLY has a worse Debt to Equity ratio (1.87) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 7.31 |
ROIC/WACC3.49
WACC8.48%
2.3 Liquidity
1LLY has a Current Ratio of 1.28. This is a normal value and indicates that 1LLY is financially healthy and should not expect problems in meeting its short term obligations.
1LLY has a Current ratio (1.28) which is in line with its industry peers.
1LLY has a Quick Ratio of 1.28. This is a bad value and indicates that 1LLY is not financially healthy enough and could expect problems in meeting its short term obligations.
1LLY has a Quick ratio (1.00) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 77.67% over the past year.
Measured over the past years, 1LLY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.57% on average per year.
Looking at the last year, 1LLY shows a very strong growth in Revenue. The Revenue has grown by 36.83%.
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
3.2 Future
Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 30.19% on average per year.
Based on estimates for the next years, 1LLY will show a quite strong growth in Revenue. The Revenue will grow by 17.70% on average per year.
EPS Next Y76.53%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
EPS Next 5Y30.19%
Revenue Next Year36.8%
Revenue Next 2Y27.26%
Revenue Next 3Y23.11%
Revenue Next 5Y17.7%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 51.16, 1LLY can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 1LLY is valued a bit more expensive than 64.81% of the companies in the same industry.
1LLY is valuated expensively when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 27.22, 1LLY can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 70.37% of the companies listed in the same industry.
1LLY is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.85, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.16 | ||
| Fwd PE | 27.22 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than 72.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 33.62 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 41.48% in the coming years.
PEG (NY)0.67
PEG (5Y)3.09
EPS Next 2Y52.79%
EPS Next 3Y41.48%
5. Dividend
5.1 Amount
With a yearly dividend of 0.70%, 1LLY is not a good candidate for dividend investing.
1LLY's Dividend Yield is comparable with the industry average which is at 3.04.
With a Dividend Yield of 0.70, 1LLY pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
5.2 History
The dividend of 1LLY is nicely growing with an annual growth rate of 15.60%!
Dividend Growth(5Y)15.6%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
36.46% of the earnings are spent on dividend by 1LLY. This is a low number and sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP36.46%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
BIT:1LLY (10/15/2025, 7:00:00 PM)
709.1
+12.2 (+1.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap671.13B
Analysts80
Price Target768.2 (8.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
Yearly Dividend4.27
Dividend Growth(5Y)15.6%
DP36.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.94%
Min EPS beat(2)9.38%
Max EPS beat(2)14.51%
EPS beat(4)3
Avg EPS beat(4)2.5%
Min EPS beat(4)-20.34%
Max EPS beat(4)14.51%
EPS beat(8)7
Avg EPS beat(8)31.01%
EPS beat(12)10
Avg EPS beat(12)22.08%
EPS beat(16)12
Avg EPS beat(16)15.86%
Revenue beat(2)1
Avg Revenue beat(2)2.11%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.72%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-6.46%
Max Revenue beat(4)4.72%
Revenue beat(8)4
Avg Revenue beat(8)1.92%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)1.54%
PT rev (1m)0.44%
PT rev (3m)-10.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.6%
EPS NY rev (1m)-0.18%
EPS NY rev (3m)5.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.13%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)3.97%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.16 | ||
| Fwd PE | 27.22 | ||
| P/S | 14.68 | ||
| P/FCF | N/A | ||
| P/OCF | 71.47 | ||
| P/B | 42.78 | ||
| P/tB | 118.56 | ||
| EV/EBITDA | 33.62 |
EPS(TTM)13.86
EY1.95%
EPS(NY)26.05
Fwd EY3.67%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)9.92
OCFY1.4%
SpS48.31
BVpS16.57
TBVpS5.98
PEG (NY)0.67
PEG (5Y)3.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.67% | ||
| ROE | 75.52% | ||
| ROCE | 36.25% | ||
| ROIC | 29.63% | ||
| ROICexc | 31.43% | ||
| ROICexgc | 39.29% | ||
| OM | 42.13% | ||
| PM (TTM) | 25.91% | ||
| GM | 82.64% | ||
| FCFM | N/A |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexcg growth 3Y1.59%
ROICexcg growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.81%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.87 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.4 | ||
| Cap/Depr | 580.51% | ||
| Cap/Sales | 20.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 7.31 |
F-Score6
WACC8.48%
ROIC/WACC3.49
Cap/Depr(3y)374.28%
Cap/Depr(5y)279.43%
Cap/Sales(3y)16.34%
Cap/Sales(5y)12.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.67%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%60.97%
EPS Next Y76.53%
EPS Next 2Y52.79%
EPS Next 3Y41.48%
EPS Next 5Y30.19%
Revenue 1Y (TTM)36.83%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%37.64%
Revenue Next Year36.8%
Revenue Next 2Y27.26%
Revenue Next 3Y23.11%
Revenue Next 5Y17.7%
EBIT growth 1Y67.12%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y29.64%
FCF growth 1Y-101.56%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y75.24%
OCF growth 3Y6.69%
OCF growth 5Y12.76%